While HHS Secretary Robert F. Kennedy has maintained that the vaccine is still available to those who want it, in practice ...

It’s no secret that while women generally live longer than men, they face a disproportionately higher burden of healthcare ...

Menopause is a natural process that occurs as women age and marks the end of their reproductive years. However, while it's a ...

The latest batch of CRLs to be made public in the US regulator's drive towards what it calls "radical transparency" includes ...

The Watertown-based company – set up by Loxo Oncology founder Josh Bilenker and Jeff Engelman, formerly head of oncology at ...

Bringing together leaders in PKPD, bioanalysis, pharmacometrics, and clinical pharmacology, the 2nd ADC Pharmacokinetics & ...

Biotech finance has encountered what can arguably be termed the worst perfect storm in its history, and private investment in ...

Donovan Quill, AscellaHealth’s Executive Vice President of Growth and Strategy, describes the unique challenges associated with bringing new specialty and rare disease pharmaceutical products to ...

Bristol-Myers Squibb’s KRAS inhibitor Krazati has been approved for a second indication, colorectal cancer (CRC), which could inject some much-needed sales growth into the product. The FDA has ...

US tariffs on goods coming from Europe, China, and Canada could have a major impact on the biopharma industry and medicines access, says BIO.

In a three-hour hearing before the Senate Finance Committee, Democrats – and a surprising number of Republicans – took HHS ...

Telehealth startup Remedy Meds has expanded its position in the US market at a stroke with a deal to buy Thirty Madison in an ...